Own Medibank (ASX:MPL) Shares? Tomorrow Is an Important Dividend Date

Sonal Goyal

01 September 2026 02:41 PM AEST

Own Medibank (ASX:MPL) Shares? Tomorrow Is an Important Dividend Date

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Medibank (ASX:MPL) goes ex-dividend on 2 September 2026.
The Dividend is 10.9 cents per share, fully franked, payable on 8 October 2026.
FY26 Revenue reached approximately A$9.1 billion, with statutory NPAT rising 27.5% to A$638.7 million.
Medibank Health delivered another record result as the company positions itself as a broader health company.

Dividend Details

Medibank (ASX:MPL) is scheduled to trade ex-dividend on 2 September 2026. Shareholders purchasing on or after this date will not be entitled to the upcoming payment; only those holding shares before the ex-date qualify. The dividend is fully franked at 100%, with a payment amount of 10.9 cents per share, due to be paid on 8 October 2026.

Company Update

Medibank reported FY2026 revenue of approximately A$9.1 billion and statutory NPAT of A$638.7 million, up 27.5%. The company highlighted stronger momentum in the Medibank brand, continued growth at ahm and another record result from Medibank Health. It is increasingly positioning itself as a broader health company, supported by technology, AI and healthcare services.

Catalysts to Watch

Continued momentum in the core Medibank Brand alongside sustained growth at ahm represents a key catalyst for the group's core Health Insurance business. Further record performance from Medibank Health would reinforce the company's Diversification beyond traditional health insurance. Progress on technology and AI initiatives supporting the broader health company positioning could also serve as a catalyst, particularly if these translate into efficiency gains or new service offerings.

Key Risks

Medibank's core health insurance Business remains subject to regulatory settings affecting premium increases and industry structure within the Australian private health insurance sector. Claims cost inflation, including from medical and hospital cost trends, represents an ongoing risk to Underwriting margins. Execution risk is relevant to the company's broader health company strategy, as successfully scaling Medibank Health and related services requires sustained Investment and operational capability. Competitive dynamics within Australian health insurance also remain relevant.

Conclusion

Medibank goes ex-dividend on 2 September 2026, with a fully franked 10.9-cent payment following a FY26 result that showed statutory NPAT rising 27.5% to A$638.7 million. Payment is due on 8 October 2026 for eligible shareholders. For investors, the growth of Medibank Health and the company's broader positioning as a health company remain key themes to watch alongside its core insurance operations.

Q1: When does Medibank (ASX:MPL) go ex-dividend?

Q2: How much is Medibank's dividend?

Q3: When will the Medibank dividend be paid?

Q4: What was Medibank's FY26 statutory NPAT?

Q5: What is Medibank Health?

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.